Pirh2 Antibodies

Santa Cruz Biotechnology features a diverse variety of Pirh2 monoclonal antibodies for advanced research in cellular regulation and protein interactions. Pirh2 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Pirh2, or p53-induced protein with a RING-H2 domain, plays a critical role in the regulation of p53, a key tumor suppressor protein. By mediating the ubiquitination and degradation of p53, Pirh2 is essential for maintaining cellular homeostasis and responding to stress signals. Understanding the function of Pirh2 is crucial for elucidating mechanisms of cancer development and progression. Researchers in oncology and cell biology rely on Pirh2 monoclonal antibodies to explore cellular pathways and protein interactions. The high specificity of Pirh2 monoclonal antibodies enables precise detection and analysis of target proteins in various experimental settings. Ongoing research with Pirh2 monoclonal antibodies continues to reveal new insights into cancer biology and cellular regulation. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.